TuHURA Biosciences, Inc./NV

HURA

TuHURA Biosciences, Inc./NV

HURA

Insider Sentiment (TTM):

Last Purchase:2022-02-15Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:9,353,544Shares Outstanding:60,010,237Institutional Ownership Pct.:15.59%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Series A Preferred Stock	-	-	-	-	-	-	-	0	0	0	0	0
Series C Preferred Stock	-	-	-	-	-	-	-	0	0	0	0	0
Related Party	-	-	-	-	-	-	-	0	-	-0	-0	0
Cash And Cash Equivalents At Carrying Value	1	6	4	3	9	6	5	3	5	6	1	0
Stockholders Equity Note Subscriptions Receivable	-	-	-	-	-	-	-	-	-	-	0	-
Assets Current
Assets Current	2	7	5	4	13	14	6	3	6	7	1	1
Prepaid Expense Current	-	-	-	-	-	-	-	0	0	0	0	1
Other Assets Current	1	1	1	1	1	1	1	-	-	-	-	-
Property Plant And Equipment Net	0	0	0	0	0	0	1	1	1	1	1	1
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	-	-	-	-	-
Other Assets Noncurrent	0	0	0	-	-	-	0	-	-	-	-	-
Goodwill	11	11	11	14	14	-	-	-	-	-	-	-
Assets	32	30	27	26	35	15	6	4	6	7	2	1
Liabilities
Liabilities Current
Accounts Payable And Accrued Liabilities Current	4	6	6	5	12	5	2	2	2	1	2	3
Liabilities Current	9	6	6	9	15	5	2	2	2	1	2	3
Other Liabilities Current	-	-	-	-	-	-	-	-	0	-	-	-
Notes Payable Current	-	-	-	0	0	-	-	-	-	-	-	-
Asset Acquisition Contingent Consideration Liabili…	-	-	-	3	3	-	-	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	-	-	-	-	-
Liabilities Noncurrent
Other Liabilities Noncurrent	-	-	-	0	-	-	-	-	-	-	-	-
Operating Lease Liability Noncurrent	0	0	0	-	-	-	0	-	-	-	-	-
Deferred Income Tax Liabilities Net	0	0	0	-	-	-	-	-	-	-	-	-
Liabilities	13	7	6	9	15	5	2	2	2	2	2	4
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	176	172	162	151	146	130	153	163	153	153	145	142
Stockholders Equity
Stockholders Equity	19	23	21	17	19	10	4	-3	4	-6	-0	-2
Retained Earnings Accumulated Deficit	-158	-149	-141	-134	-127	-118	-160	-162	-160	-158	-156	-155
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	-	-	-	-	0	0	0	0	0
Liabilities And Stockholders Equity	32	30	27	26	35	15	6	4	6	7	2	1
Preferred Stock Shares Authorized	-	-	5	-	-	-	5	5	5	5	5	5
Preferred Stock Par Or Stated Value Per Share	-	-	-	-	-	-	-	0.001	0.001	0.001	0.001	0.001
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	75	75	75	75	75	75	75
Common Stock Shares Issued	64	64	59	51	50	44	55	2	55	55	10	2
Shares Outstanding	64	64	59	51	50	44	12	-	-	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-5.37%	-63.41%	-73.90%	-	-	-	-14.94%	5.63%	-6.06%	-	-	-
2025	36.33%	-8.37%	1.84%	-7.61%	-5.80%	-7.61%	-26.82%	-35.42%	-37.50%	31.28%	39.66%	43.58%
2024	-42.12%	-57.34%	-66.03%	-18.18%	18.18%	37.27%	64.06%	134.37%	40.63%	-11.68%	-4.86%	-36.04%
2023	-	-	-	-	-	-	-	-	-	-6.79%	-89.59%	-94.21%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.18	1.15	0.78	0.40	0.83	3.00	2.45	1.54	2.45	5.04	0.63	0.23
Quick Ratio	0.18	1.15	0.78	0.40	0.83	3.00	2.45	1.43	2.26	4.88	0.47	0.06
Working Capital	-7.60M	915.38K	-1.30M	-5.33M	-2.63M	9.54M	3.27M	1.23M	3.27M	5.41M	-684.00K	-2.55M
Leverage & Debt
Debt to Equity	0.72	0.28	0.31	0.53	0.78	0.49	0.65	-0.88	0.65	-0.25	-12.49	-1.73
Interest Coverage TTM	-61.89	-708.47	-1,852.70	-6.84	-4.78	-3.07	-2.69	-6.27	-33.61	-50.11	-	-
Debt Ratio	0.42	0.22	0.23	0.35	0.44	0.33	0.39	0.59	0.39	0.20	1.09	2.37
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.49	-0.52	-0.64	-0.45	-0.50	-0.28	-0.85	-0.98	-0.68	-1.03	-0.92	-
Free Cash Flow Per Share TTM	-0.59	-0.59	-0.75	-0.40	-0.27	-0.13	-0.18	-0.58	-0.27	-0.72	-1.56	-139.04
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.16
Growth Metrics
Net Income Growth (1Y)	40.32%	158.21%	195.14%	91.44%	167.13%	-2.68%	-5.29%	-11.08%	-44.60%	-25.27%	-41.93%	-37.15%
EPS Growth (1Y)	-2.26%	86.76%	62.28%	-53.98%	57.99%	-72.70%	-84.41%	-99.64%	-96.59%	-89.68%	-78.00%	1,777.78%
Valuation Metrics
P/E TTM	-4.80	-3.41	-1.19	-5.51	-4.47	-11.50	-10.39	-6.98	-29.93	-3.54	-2.36	-0.52
P/B TTM	8.09	4.63	1.73	7.49	5.11	14.22	28.69	-30.04	66.28	-7.30	-157.35	-3.42
Market Cap	149.67M	107.42M	36.28M	125.65M	99.36M	140.20M	107.78M	83.12M	249.03M	44.31M	25.81M	6.93M
Enterprise Value	148.68M	101.12M	32.66M	123.45M	91.28M	133.98M	108.21M	63.52M	249.45M	39.85M	25.15M	6.71M
Calculated Values
Free Cash Flow TTM	-37.93M	-35.49M	-35.81M	-20.14M	-12.13M	-5.75M	-4.80M	-7.01M	-7.18M	-8.78M	-6.77M	-6.81M
Net Debt	-995.98K	-6.30M	-3.62M	-2.20M	-8.08M	-6.22M	426.49K	-19.60M	426.49K	-4.46M	-658.00K	-216.00K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2022-02-15Purchase

Owner: Hoffman, Robert E.

Title: President and CEO

Shares: 55,000

Price/Share: $0.47

Value: $25,850.00

Shares Owned: 55,000

Relationship: Director,Officer

Ownership: Direct

2021-12-08Purchase

Owner: Praill, Anthony Scott

Title: Chief Financial Officer

Shares: 28,700

Price/Share: $0.68

Value: $19,516.00

Shares Owned: 37,186

Relationship: Officer

Ownership: Direct

2021-12-07Purchase

Owner: Zarrabian, Saiid

Title: Head of Strategic Partnerships

Shares: 38,109

Price/Share: $0.64

Value: $24,389.76

Shares Owned: 55,500

Relationship: Director,Officer

Ownership: Direct

2021-11-22Purchase

Owner: Johnson, Laura L.

Title: -

Shares: 3,000

Price/Share: $0.74

Value: $2,220.00

Shares Owned: 3,000

Relationship: Director

Ownership: Direct

2020-08-19Purchase

Owner: Liatos, John

Title: SVP, Business Development

Shares: 196,750

Price/Share: -

Value: -

Shares Owned: 196,750

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2022-02-15	Hoffman, Robert E.	Director,Officer	President and CEO	Direct	Purchase	55,000	0.47	$25,850.00	55,000	4
2021-12-08	Praill, Anthony Scott	Officer	Chief Financial Officer	Direct	Purchase	28,700	0.68	$19,516.00	37,186	4
2021-12-07	Zarrabian, Saiid	Director,Officer	Head of Strategic Partnerships	Direct	Purchase	38,109	0.64	$24,389.76	55,500	4
2021-11-22	Johnson, Laura L.	Director	-	Direct	Purchase	3,000	0.74	$2,220.00	3,000	4
2020-08-19	Liatos, John	Director,Officer	SVP, Business Development	Direct	Purchase	196,750	-	-	196,750	4
2020-08-19	Murphy, Keith	Director	-	Direct	Purchase	181,010	-	-	181,010	4
2019-09-13	Bell, John K	Director	-	Indirect	Purchase	35,000	0.68	$23,800.00	35,000	4/A
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

15.59%

Inst. Shares: 9,353,544

Shares Outstanding: 60,010,237

2025-12-31

13.38%

Inst. Shares: 6,412,882

Shares Outstanding: 47,927,196

2025-09-30

11.95%

Inst. Shares: 6,052,347

Shares Outstanding: 50,666,430

2025-06-30

14.05%

Inst. Shares: 6,258,903

Shares Outstanding: 44,555,095

2025-03-31

8.38%

Inst. Shares: 3,636,045

Shares Outstanding: 43,404,947

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	9,353,544	60,010,237	15.59%
2025-12-31	6,412,882	47,927,196	13.38%
2025-09-30	6,052,347	50,666,430	11.95%
2025-06-30	6,258,903	44,555,095	14.05%
2025-03-31	3,636,045	43,404,947	8.38%
2024-12-31	2,160,513	18,662,690	11.58%
2024-09-30	834,851	12,178,522	6.86%
2024-06-30	818,716	26,352,000	3.11%
2024-03-31	413,845	12,173,732	3.40%
2023-12-31	114,301	4,337,000	2.64%
2023-09-30	65,797	49,000	134.28%
2023-06-30	34,503	1,620,000	2.13%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

TuHURA Biosciences, Inc./NV (HURA) — SEC Financial Statements & Analysis

TuHURA Biosciences, Inc./NV (HURA) is a pharmaceutical preparations company, incorporated in NV. TuHURA Biosciences, Inc./NV trades on Nasdaq as: HURA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), TuHURA Biosciences, Inc./NV reported a Debt-to-Equity ratio of 0.72x, a Price-to-Book (P/B) ratio of 8.09x (TTM), at a market cap of $149.67M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.72x
P/B TTM: 8.09x
Market Cap: $149.67M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is TuHURA Biosciences, Inc./NV in?

TuHURA Biosciences, Inc./NV (HURA) operates in the Pharmaceutical Preparations industry.

What is HURA's market cap?

TuHURA Biosciences, Inc./NV (HURA) has a market capitalization of $149.67M as of 2026-06-30.

What exchange does HURA trade on?

TuHURA Biosciences, Inc./NV (HURA) trades on the Nasdaq.

Where is TuHURA Biosciences, Inc./NV incorporated?

TuHURA Biosciences, Inc./NV is incorporated in NV.